1H-1,2,3-Triazol-1-yl acetate derivatives and in vitro anti-HBV activity

LIANG Zheng-cheng,SHI Kai-chuang,WANG Mian,LIANG Tao-yuan,WEI Wan-xing
DOI: https://doi.org/10.14142/j.cnki.cn21-1313/r.2023.03.002
2023-01-01
Abstract:1H-1,2,3-Triazole ring derivatives were designed and synthesized from indole, and measured for anti-HBV activity in vitro.Fourteen target compounds were obtained from substituted indoles by substitution and cycloaddition reaction.The structures of the compounds were characterized by ~1H-NMR, 13 C-NMR and MS methods.HepG2.2.15 was used as a cell model to test the anti-HBV activity in vitro,and the effects of the compound on the secretion of hepatitis B surface antigen(HBsAg) and hepatitis B e antigen(HBeAg) in vitro were tested.Compounds 3c,3d,3m and 3n can inhibit the secretion of HBeAg and HBsAg.Meanwhile, compound 2-(4-((5-chloro-1H-indol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)ethyl acetate(IC 50 =75.41 μmol · L -1 ,SI=9.23) can better inhibit HBV DNA than other compounds synthesized.The indole 5-position halogen atom had obvious effect on inhibiting the secretion HBV.
What problem does this paper attempt to address?